Maxime Brunet
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Prognostic significance of tumor fraction in advanced sarcoma: highlighting a novel circulating biomarker.
Journal: Clinical and experimental medicine
Published: January 16, 2026
Extreme plate boundary localization promotes shallow earthquake slip at the Japan Trench.
Journal: Science (New York, N.Y.)
Published: December 18, 2025
Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial.
Journal: ESMO open
Published: November 11, 2025
Metastatic osteosarcoma, patterns of care and outcomes of patients in a real-life national setting over a decade.
Journal: International journal of cancer
Published: March 05, 2025
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside.
Journal: Med (New York, N.Y.)
Published: September 30, 2024
Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures.
Journal: Cell reports. Medicine
Published: July 09, 2024
Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response.
Journal: Cell reports. Medicine
Published: April 18, 2024
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.
Journal: British journal of cancer
Published: March 31, 2024
Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: September 27, 2022
Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 30, 2022
Mature tertiary lymphoid structure is a specific biomarker of cancer immunotherapy and does not predict outcome to chemotherapy in non-small-cell lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 17, 2022
Last Updated: 09/26/2026